Endoscopic Surgery for Bariatric Revision After Weight Loss Failure
Launched by UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · Jun 4, 2013
Trial Information
Current as of June 22, 2025
Completed
Keywords
ClinConnect Summary
The most effective weight loss procedures in the United States are both roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG)where the majority are performed laparoscopically. Estimated excess body weight loss (EBWL) is \>50% at the end of one year. However, nearly 20% of patients fail to meet the estimated EBWL or they may experience weight gain recidivism. The first step is nutritional counseling, medically supervised diets, and medical therapy. Surgery would be for those who still fail to lose weight despite the aforementioned efforts.
It is hypothesized that failure of weight los...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Previous Roux-En-Y Gastric Bypass (RYGB) or Sleeve Gastrectomy (SG)
- • Failure to lose \>50% of their excess body weight after 1 year
- • Failure of weight loss despite maximal medical therapy and medically-supervised diets
- Exclusion Criteria:
- • Esophageal Stricture
- • Marginal Ulcer at the gastrojejunostomy anastomosis
- • Non-compliance with bariatric follow-up
- • Gastric ulcers
- • Paraesophageal hernias
About University Of California, San Francisco
The University of California, San Francisco (UCSF) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a focus on translating scientific discoveries into effective therapies, UCSF collaborates with a diverse array of stakeholders, including healthcare professionals, industry partners, and patient communities. The university's research programs emphasize interdisciplinary approaches and leverage cutting-edge technology to address complex medical challenges. As a sponsor of clinical trials, UCSF is dedicated to maintaining the highest standards of ethical conduct and scientific rigor, ensuring the safety and well-being of participants while contributing to the broader medical knowledge base.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Francisco, California, United States
Patients applied
Trial Officials
Stanley J Rogers, MD
Principal Investigator
University of California, San Francisco
Jonathan T Carter, MD
Principal Investigator
University of California, San Francisco
John P Cello, MD
Principal Investigator
University of California, San Francisco
Matthew Lin, MD
Principal Investigator
University of California, San Francisco
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials